ATE352294T1 - Transdermales therapeutisches system mit zwei übereinanderliegenden matrixschichten, die verschiedene affinitäten zum enthaltenen wirkstoff ausweisen - Google Patents

Transdermales therapeutisches system mit zwei übereinanderliegenden matrixschichten, die verschiedene affinitäten zum enthaltenen wirkstoff ausweisen

Info

Publication number
ATE352294T1
ATE352294T1 AT03722872T AT03722872T ATE352294T1 AT E352294 T1 ATE352294 T1 AT E352294T1 AT 03722872 T AT03722872 T AT 03722872T AT 03722872 T AT03722872 T AT 03722872T AT E352294 T1 ATE352294 T1 AT E352294T1
Authority
AT
Austria
Prior art keywords
active ingredients
therapeutic system
exhibit different
transdermal therapeutic
ingredients contained
Prior art date
Application number
AT03722872T
Other languages
English (en)
Inventor
Francisco Jose Evarist Stefano
Alejandro Fabio Scasso
Original Assignee
Thalas Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thalas Group Inc filed Critical Thalas Group Inc
Application granted granted Critical
Publication of ATE352294T1 publication Critical patent/ATE352294T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03722872T 2002-05-15 2003-05-15 Transdermales therapeutisches system mit zwei übereinanderliegenden matrixschichten, die verschiedene affinitäten zum enthaltenen wirkstoff ausweisen ATE352294T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP020101791A AR033748A1 (es) 2002-05-15 2002-05-15 Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo

Publications (1)

Publication Number Publication Date
ATE352294T1 true ATE352294T1 (de) 2007-02-15

Family

ID=38561712

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03722872T ATE352294T1 (de) 2002-05-15 2003-05-15 Transdermales therapeutisches system mit zwei übereinanderliegenden matrixschichten, die verschiedene affinitäten zum enthaltenen wirkstoff ausweisen

Country Status (9)

Country Link
US (1) US8017146B2 (de)
EP (1) EP1503743B1 (de)
AR (1) AR033748A1 (de)
AT (1) ATE352294T1 (de)
AU (1) AU2003230032A1 (de)
DE (1) DE60311449T2 (de)
ES (1) ES2281641T3 (de)
MX (1) MXPA04011214A (de)
WO (1) WO2003097020A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004009903A1 (de) 2004-02-26 2005-09-22 Grünenthal GmbH Pflaster mit reduzierter Hautirritation
US20050202073A1 (en) 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US9205062B2 (en) 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
WO2007095147A2 (en) * 2006-02-13 2007-08-23 Aveva Drug Delivery Systems Adhesive preparation comprising sufentanil and methods of using the same
DE102006054733A1 (de) 2006-11-21 2008-05-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit
WO2008083034A1 (en) * 2006-12-27 2008-07-10 Nexagen Usa, Llc Transdermal vitamin b12 delivery patch
JP5275047B2 (ja) * 2007-01-31 2013-08-28 久光製薬株式会社 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤
MY154027A (en) * 2007-10-15 2015-04-30 Alza Corp Once-a-day replacement transdermal administration of fentanyl
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
MX350636B (es) 2010-03-26 2017-09-12 Philip Morris Products Sa Inhibicion de irritacion sensorial durante el consumo de productos de tabaco no fumables.
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
EP3064199B1 (de) * 2010-04-02 2023-12-20 Buzzz Pharmaceuticals Limited Missbrauchssichere transdermale formulierungen von opiat-agonisten und -agonist-antagonisten
WO2013119419A1 (en) 2012-02-08 2013-08-15 North Carolina State University Treatment of allergic diseases with recombinant antibodies
AR095259A1 (es) * 2013-03-15 2015-09-30 Noven Pharma Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
KR101891185B1 (ko) 2013-10-07 2018-08-24 테이코쿠 팔마 유에스에이, 인코포레이티드 비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물
RU2646512C2 (ru) * 2013-10-07 2018-03-05 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Устройства для трансдермальной доставки дексмедетомидина и способы их применения
TWI709417B (zh) 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
WO2016100708A1 (en) * 2014-12-19 2016-06-23 3M Innovative Properties Company Transdermal drug delivery device including fentanyl
KR20190060007A (ko) 2016-10-31 2019-05-31 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치를 이용한 통증을 관리하는 방법
JP7127859B2 (ja) 2016-11-09 2022-08-30 ノース カロライナ ステート ユニバーシティ キメラタンパク質を用いたアレルギー疾患の治療
RU2019143747A (ru) * 2017-06-08 2021-07-09 Априкот Гмбх Силиконовый тампон с активными веществами для ухода за кожей и против старения кожи
WO2019183437A1 (en) 2018-03-23 2019-09-26 North Carolina State University Methods and compositions for antibody to high affinity receptor for ige
US20220370374A1 (en) * 2019-10-16 2022-11-24 Kyushu University, National University Corporation Transdermal absorption-type patch
CN115245351A (zh) * 2021-04-27 2022-10-28 山东第一医科大学附属皮肤病医院(山东省皮肤病性病防治研究所、山东省皮肤病医院) 皮肤斑贴试验在制备氨苯砜综合征诊断产品中的应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436741A (en) 1975-12-08 1984-03-13 Alza Corporation Method for administering scopolamine transdermally
US4262003A (en) 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
US4031894A (en) 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4060084A (en) 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4201211A (en) 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
US4286592A (en) 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US5310559A (en) 1982-09-01 1994-05-10 Hercon Laboratories Corporation Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
DE3315272C2 (de) 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US4938759A (en) 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
US5006342A (en) 1986-12-22 1991-04-09 Cygnus Corporation Resilient transdermal drug delivery device
US4906463A (en) 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5004610A (en) 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
DE3908432A1 (de) * 1989-03-14 1990-09-27 Lohmann Therapie Syst Lts Pflaster als therapeutisches system zur verabreichung von wirkstoffen an die haut mit einer abgestuften wirkstoffabgabe, verfahren zu seiner herstellung sowie verwendung
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
DE4223360C1 (de) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device
DE19527925C2 (de) 1995-07-29 1997-07-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer trennmittelbeschichteten Schutzschicht
US6174545B1 (en) 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
AU3470600A (en) 1999-01-14 2000-08-01 David Houze Compositions and methods for drug delivery
KR20010036685A (ko) 1999-10-11 2001-05-07 김윤 펜타닐을 함유하는 매트릭스형 경피투여제
FR2801507B1 (fr) 1999-11-30 2003-06-27 Pf Medicament Dispositif transdermique auto-adhesif comprenant un reservoir et une matrice contenant le meme principe actif, son procede de preparation et ses utilisations
US20020119187A1 (en) 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
WO2004098472A1 (en) 2002-08-30 2004-11-18 Watson Pharmaceuticals, Inc. Transdermal delivery systems and methods

Also Published As

Publication number Publication date
DE60311449D1 (de) 2007-03-15
WO2003097020A1 (en) 2003-11-27
AR033748A1 (es) 2004-01-07
DE60311449T2 (de) 2007-11-08
AU2003230032A1 (en) 2003-12-02
US20050208116A1 (en) 2005-09-22
MXPA04011214A (es) 2005-11-04
EP1503743A1 (de) 2005-02-09
ES2281641T3 (es) 2007-10-01
US8017146B2 (en) 2011-09-13
EP1503743B1 (de) 2007-01-24

Similar Documents

Publication Publication Date Title
DE60311449D1 (de) Transdermales therapeutisches system mit zwei übereinanderliegenden matrixschichten, die verschiedene affinitäten zum enthaltenen wirkstoff ausweisen
IL183871A0 (en) Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same
DE602004018299D1 (de) Medizinprodukt mit therapeutischen mitteln
DE60316552D1 (de) Tablette mit hohem wirkstoffgehalt
DE60308332D1 (de) Chinazolinverbindungen mit therapeutischem nutzen
NO20053297D0 (no) Inhaleringsinnretning for transpulmonaer administrering.
EP1390991A4 (de) Aktive einrichtungen, die threads benutzen
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
AT10109U3 (de) Fentanyl-hältiges, transdermales, therapeutisches system
PL369889A1 (en) Anticholinergic agents, method for producing the same and use thereof as medicaments
ES1058674Y (es) Maquina licuadora perfeccionada.
ITMI20030900A1 (it) Macchina circolare per maglieria, particolarmente per la
AU2003301405A8 (en) Prepolymeric materials for site specific delivery to the body
ZA200705119B (en) Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same
ITPR20020027A1 (it) Ampolla nebulizzatrice, in particolare per aerosolterapia.
DE50208711D1 (de) Vorrichtung zum Umhüllen von Körpern
DE502005003816D1 (de) System zum Erzeugen von Lenkwinkeln
ITMI20022658A1 (it) Farmaci per il dolore cronico.
DE602004031726D1 (de) Indazole mit analgetischer aktivität
AU2003278051A8 (en) Electroluminescent textile structure, in particular for medical use
ITMO20020343A1 (it) Macchina per distribuire bevande.
ITMI20022389A1 (it) Farmaci per le disfunzioni sessuali.
AT500784A3 (de) Vorrichtung zum herstellen von polsterförmigen, vorzugsweise gefüllten hohlkörpern
IL165085A0 (en) Progestagenic dosage units
MY146552A (en) Retard formulation for pralnacasan

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties